Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV

Comparison of DNA vaccines with AS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2 - ScienceDirect

DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice

COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models - ScienceDirect

Vaccines, Free Full-Text

Advances in the design and development of SARS-CoV-2 vaccines, Military Medical Research

Immunogenicity of a DNA vaccine candidate for COVID-19

Inovio Pharmaceuticals, Inc. - INOVIO Announces Publication of Phase 1 Data from its COVID-19 DNA Vaccine Candidate, INO-4800 in The Lancet's EClinicalMedicine

Enhanced immunogenicity elicited by a novel DNA vaccine encoding the SARS- CoV-2 S1 protein fused to the optimized flagellin of Salmonella typhimurium in mice

The 2020 race towards SARS-CoV-2 specific vaccines